Osteoporosis is a common disease with a strong genetic component, characterized by reduced bone mass and an increased risk of fracture. Bone mineral density (BMD) is a highly heritable trait and a key determinant of osteoporotic fracture risk, but the genes responsible are incompletely defined. Here, we identified quantitative trait loci (QTL) for regulation of BMD by a genome wide scan involving 3691 individuals from 715 families, who were selected because of reduced BMD values at the lumbar spine (LS-BMD) or femoral neck (FN-BMD) in probands. Linkage analysis was conducted in the study group as a whole with correction for age, gender, weight and height. Further analyses were conducted for men and women separately to identify gender-specific QTL and for those under and over the age of 50 years to distinguish QTL for peak bone mass from those that influence bone mass in older people. No regions of suggestive or significant linkage were identified when data from all subjects were analyzed together. On subgroup analysis, however, we identified a significant QTL for FN-BMD on chromosome 10q21 (LOD score 14.42; men 50 years) and two suggestive QTL for LS-BMD on chromosomes 18p11 (LOD score 12.83; women >50 years) and 20q13 (LOD score 13.20; women 50 years). We identified five other QTL for BMD with LOD scores of greater than 12.20 on chromosomes 3q25, 4q25, 7p14, 16p13 and 16q23. This study provides evidence for gender-specific, site-specific and age-specific QTL, which regulate BMD in humans, and illustrates the importance of conducting subgroup analysis to detect these loci.
INTRODUCTION
Osteoporosis is a common disease with a strong genetic component, characterized by reduced bone mass and an increased risk of fragility fractures. Bone mineral density (BMD) is one of the most important clinical predictors of osteoporotic fracture risk, and evidence from twin and family studies suggests that between 50 and 85% of the variance in BMD # The Author 2005. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org *To whom correspondence should be addressed at: Rheumatic Diseases Unit, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK. Tel: þ44 1315371088; Fax: þ44 1315371051; Email: stuart.ralston@ed.ac.uk Human Molecular Genetics, 2005, Vol. 14, No. 7 943-951 doi:10.1093/hmg/ddi088 Advance Access published on March 3, 2005 is genetically determined (1 -3) . Polymorphisms have been identified in many candidate genes that are associated with BMD or osteoporotic fractures, but these account for only a small proportion of the genetic contribution to BMD regulation and the susceptibility to osteoporotic fractures (4 -6) .
Several genome wide linkage scans have been performed to try and identify quantitative trait loci (QTL) that regulate BMD. A variety of study designs have been used including analysis of families with a history of osteoporosis (7 -10) families drawn from the normal population (11, 12) , healthy sib-pairs (13 -16) and dizygotic twins (14) . Few of these studies have identified QTL which meet the criteria for genome wide significance, and only one gene which regulates susceptibility to osteoporosis has been identified by genome wide scan and positional cloning (10) . Identification of the genes and QTL that regulate BMD in osteoporosis has been made difficult by factors such as genetic heterogeneity and the fact that the effect size of susceptibility genes is modest. There is also evidence to suggest that the genes that regulate BMD act in a gender-specific, age-specific and site-specific manner. For example, linkage studies using inbred strains of mice have shown that the loci which regulate BMD are gender-specific (17, 18) and emerging data suggests that this is also true in humans (12,19 -21) . The loci that regulate peak bone mass have also been found to differ from those that regulate bone mass in older people (12, 19) , and it is clear that different loci are responsible for regulation of BMD at different skeletal sites (7, 9, 11, 13, 19) . Relatively few linkage studies have attempted to separate the influences of age and gender on the regulation of BMD, either because of the fact that only women were studied or because of limited statistical power due to small sample size (7, 9, 12, 19) . Here, we report the results of a large-scale genome wide linkage scan for BMD in 3691 individuals from 715 families in which we used subgroup analysis to identify gender-specific, age-specific and site-specific loci for the regulation of BMD.
RESULTS
Relevant demographic details of the study subjects and their site of recruitment are shown in Table 1 . Most subjects were recruited from centers in the UK (63%), with 19% from Denmark and 18% from the Netherlands. The median age of participants was 50 years with a range of 19 -96 years. There was no significant difference between centers in age, BMD values or gender distribution of participants. Heritability estimates of LS-BMD, with adjustment for ascertainment, as estimated by SOLAR, were (mean + SE) 0.55 + 0.05 in women and 0.72 + 0.07 in men. Corresponding values for FN-BMD were 0.66 + 0.05 in women and 0.63 + 0.07 in men.
We initially performed linkage analysis for BMD at the spine and hip in the whole study population, but no regions of suggestive or significant linkage were identified, and the highest LOD score recorded was þ2.00 for FN-BMD on chromosome 1 at 255 cM between the markers D1S2800 and D1S2850. In view of this, we conducted a subgroup analysis for men and women separately and for those aged under and over 50 years. Results of this analysis are shown in Figure 1 for men and in Figure 2 for women. We identified five QTL in men that showed suggestive or significant evidence of linkage (Fig. 1 ). These were on chromosome 3q25 for LS-BMD at 177 cM between the markers D3S1279 and D3S1565 (LOD score þ2.43, men age 50), on chromosome 4q25 for FN-BMD at 117 cM between the markers D4S1572 and D4S406 (LOD score þ2.22, men age 50), on chromosome 7p14 for FN-BMD at 57 cM between the markers D7S516 and D7S510 (LOD score þ2.28, men age .50), on chromosome 10q21 for FN-BMD at 80 cM between the markers D10S196 and D10S537 (LOD score þ4.42, men age 50) and on chromosome 16p13 for FN-BMD at 31 cM between the markers D16S3075 and D16S261 (LOD score þ2.52, men age 50). We identified four QTL in women that showed suggestive evidence of linkage (Fig. 2 ). These were on chromosome 4q25 for FN-BMD at 117 cM between the markers D4S1572 and D4S406 (LOD score þ2.55, women age .50), on chromosome 16q23 for LS-BMD at 31 cM between the markers D16S3091 and D16S520 (LOD score þ2.28, women age 50), on chromosome 18p11 for LS-BMD at 48 cM between the markers D18S53 and D18S478 (LOD score þ2.83; women age .50) and on chromosome 20q13 for LS-BMD at 90 cM between the markers D20S196 and D20S173 (LOD score þ3.20, women age 50). Figures 3 and 4 show detailed LOD score plots for LS-BMD and FN-BMD on chromosomes where QTL with LOD scores of greater than þ2.2 were identified. The plots for men are shown in Figure 3 and for women in Figure 4 . These figures illustrate that the loci identified for BMD regulation are largely gender specific, age-group specific and site specific. We identified one locus on chromosome 4q25 where we found evidence of suggestive linkage to FN-BMD in both men and women, although the linkage signal in men was for subjects aged 50 and in women was for subjects aged .50 ( Figs 3B and 4A ). This presumably explains why we did not detect a clear signal at chromosome 4q25 in the pooled analysis where the maximum LOD score in this region was only þ0.60 at D4S1572.
We also calculated two-point LOD scores for markers adjacent to the regions where multipoint LOD scores exceeded þ2.2. The results of this analysis showed reasonable concordance between the two-point and the multipoint analyses but with generally lower LOD scores in the two-point analysis (data not shown), due presumably to the fact that the two-point analysis is less informative because it does not take into account haplotype information from adjacent markers.
The results obtained in this study were compared with those of previous investigators who also conducted genome wide scans for BMD QTL (Table 2 ). This analysis was restricted to loci identified in previous studies where the LOD score was more than or equal to þ1.7. Three regions were identified where LOD scores of more than or equal to þ1.0 were observed in this study at loci identified by previous investigators and being potentially linked with BMD. For the chromosome 1q21, LS-BMD locus initially identified by Koller et al. The number of families and individuals enrolled in each center are shown and the gender distribution is expressed as the percent of females in each center. The values for BMD Z-scores are mean and standard deviation (SD). FN-BMD is femoral neck BMD and LS-BMD is lumbar spine BMD.
DISCUSSION
This is the largest family-based genome wide scan for BMD so far reported with a sample size of 30% greater than the next largest study. Despite this, linkage analysis in the study group as a whole yielded disappointing results in that no regions of suggestive or significant linkage were identified. In view of this, we conducted genome wide scans for men and women separately in the light of previous studies, which suggest that there are important gender differences in the genetic regulation of BMD (12, 19, 20, 22) . We also subdivided subjects into two broad categories by age to explore the possibility that the loci which regulate peak bone mass may differ from those that regulate bone mass in older people. For this analysis, we chose an age cutoff of 50 years because this was the median age of participants in the study and is also close to the average age at menopause in women. As in previous genome wide linkage scans, we found little overlap between QTL for lumbar spine and femoral neck BMD, supporting the view that different genes regulate BMD at these different skeletal sites (7, 11, 13, 14) . We also found that there was limited overlap between QTL in men and women. This supports the findings that have previously been observed in mice (17) and humans (12, 19) and demonstrates that for the most part, different genes regulate bone mass in different genders. We also found that different QTL were identified in subgroups of individuals older and younger than 50 years. This suggests that different genes may be responsible for regulating peak bone mass and bone loss, although it should be acknowledged that we did not measure bone loss directly in this study. None of the major QTL identified in this study overlapped with major QTL identified by previous investigators who have conducted genome wide scans for BMD. Despite this, we found positive LOD scores in three QTL identified by previous workers. These were in the 1q21 locus for LS-BMD identified by Koller et al., (13) where we observed a LOD score for LS-BMD of þ1.11 at D1S484 in women ,50 years, which coincides exactly with the position of the LOD score peak previously reported. This lends support to the hypothesis that there may be an important gene on chromosome 1q21, which regulates peak bone mass in women. We also observed a LOD score of þ1.31 for LS-BMD at 56 cM on chromosome 14q31, when all subjects were analyzed together, coinciding with a linkage peak of þ1.92 in the same chromosomal region identified by Karasik et al. (11) . Finally, we observed a LOD score of þ1.13 at 55 cM on chromosome 3p24 in men, coinciding with the linkage peak of þ1.81 identified at this locus by Kammerer et al. (12) in Mexican-American men. The fact that we failed to replicate other QTL identified previously could be due to a number of factors including differences in study design and selection of probands; differences in environmental interactions, and the possibility that different genes regulate BMD in different human populations. In this study, we used a family-based design, with selection of probands on the basis of low BMD, broadly similar to the approaches used by Deng et al. (9), Devoto et al. (7) and Styrkarsdottir et al. (10) . The BMD cutoff for proband enrollment in this study was more stringent than those in the family-based studies cited previously, which could have resulted in enrichment for genes that predispose to severe osteoporosis. It is of interest that the QTL on chromosomes 3q25 and 16p13 which we identified are syntenic with those identified as regulators of BMD in mice (23 -25) . Although this may indicate the presence of shared genes that regulate BMD across species, caution need to be exercised in interpreting the data in light of the fact that BMD QTL have now been identified in mice on almost all chromosomes (26) .
The findings reported in this study need to be interpreted with caution in view of the subgroup analysis we performed. Application of a Bonferroni correction for the number of analyses conducted increases the accepted LOD score thresholds (27) for suggestive linkage from þ2.2 to þ2.8 and those for significant linkage from þ3.6 to þ4.1. According to these criteria, we identified one QTL where the LOD score was above the threshold for significant linkage and two QTL where the LOD score exceeded the threshold for suggestive linkage. However, another six QTL were identified where the LOD scores were in excess of þ2.2, and it is likely that some of these regions contain genes that regulate BMD, because the analyses we performed were not independent and so the true thresholds for significance probably lie somewhere between the corrected and uncorrected thresholds for genome wide significance.
Some interesting positional candidate genes are present within the 10p21 and 20q13 loci which we identified. For example, the chromosome 20q13 locus contains the GNAS1 gene, which is involved in the pathogenesis of both pseudohypoparathyroidism and Albright's hereditary osteodystrophy. This is an interesting candidate gene in light of the fact that it is imprinted resulting in different phenotypes depending on the parental origin of the mutation (28) . A strong candidate gene within the 20q13 locus is BMP-7, which is known to promote bone formation in vivo and osteoblast differentiation in vitro. The chromosome 10q21 locus contains another strong candidate gene in the form of DKK1 which encodes the Dickkopf protein. This is an antagonist of wnt signaling, which is relevant in light of the recent data, which has shown that the wnt-LRP5 pathway plays an important role in bone formation and regulation of bone mass (29 -31) . In summary, this study provides evidence to show that the genes which regulate BMD do so in a gender-specific, sitespecific and age-specific manner. An important finding to emerge from our study was that the loci which we identified only became apparent when we conducted a subgroup analysis with conditioning by gender and age group. This has also been reported by previous workers (12, 19) and shows that inclusion of gender and age into the linkage model is less powerful than subgroup analysis in identifying gender-specific and agespecific effects. Also taking account of the fact that several analyses were conducted, we identified two loci where the LOD scores exceeded the threshold for suggestive linkage and one locus where the LOD score exceeded the threshold for significant linkage, and further studies are now warranted to identify the genes responsible for BMD regulation in these regions.
MATERIALS AND METHODS

Subjects
Participants were recruited from eight European referral centers for investigation and management of osteoporosis between 1999 and 2001. The centers were in Aarhus (Denmark), Aberdeen (UK), Cambridge (UK), Glasgow (UK), London (UK), Oxford (UK), Rotterdam (Netherlands) and Southampton (UK). The study protocol was approved by the Multicentre Research Ethics Committee in the UK and by the local research ethics committees of all participating centers. Subjects were recruited from a combination of clinical referrals and BMD screening programs in different centers and all subjects enrolled gave informed written consent. We recruited subjects into the study on the basis that the probands were between 18 and 90 years of age with a BMD Z-score value of less than 22.0 or at the spine or hip, which approximates to the lowest 2.5% of the population distribution of BMD values. This method of selection was used because it is believed to have greater statistical power than that of random sampling (32) . All consenting individuals from the immediate family were enrolled, irrespective of their BMD values. We also extended recruitment beyond the immediate family of each proband by enrolling relatives of family members whose BMD Z-score values were less than 21.28 (approximating to the lowest 10% of the population distribution). All subjects completed a nurse-administered questionnaire on medical history and drug treatment and underwent a routine biochemistry and hematology screen. Subjects were excluded if they had an early menopause (age ,45 years), prolonged amenorrhea (.5 years), a history of thyroid disease with suppressed TSH values at the time of treatment, evidence of chronic liver disease (AST levels more than twice the upper limit of normal), evidence of chronic renal disease (serum creatinine levels more than twice the upper limit of normal), a history of malignant disease (except localized basal carcinoma of the skin), chronic inflammatory disease or malabsorption. Subjects who had received HRT and other bone active drugs, such as bisphosphonates, were eligible for inclusion in the study, but in these subjects, BMD values used in the linkage analysis were those taken before treatment had been commenced. All of the study subjects were Caucasians of European descent. The final study group comprised 715 pedigrees with 3691 subjects.
However, BMD measurements were not obtained in 33 subjects resulting in a final study group of 3658 subjects [1398 (38%) men and 2260 (62%) women]. The pedigrees ranged in size from three to 50 subjects (average 8.06) and from two to five (average 2.85) generations.
BMD measurements
BMD measurements were made at the lumbar spine [mean of lumbar vertebrae 2, 3 and 4 (LS-BMD)] and the femoral neck (FN-BMD) by dual energy X-ray absorptiometry (DXA) using one of the following types of scanner: Hologic QDR1000, Hologic QDR4500, Lunar Expert, Lunar DPX or DPXL and Norland XR26 or XR36. These DXA machines were crosscalibrated using the European Spine Phantom (33) , and the method of calibration was validated in a collection of 991 female non-proband participants of the study (manuscript in preparation). Corrected BMD values were adjusted for age and sex, using data from the study population to generate Z-scores at the lumbar spine (L2 -L4) and the femoral neck. The correction for age was modeled by a non-linear curve fitted to the calibrated data from the study population.
DNA extraction and genotyping
Venous blood (50 ml) was obtained from each subject and DNA was extracted by standard techniques. Genotyping was performed using a panel of fluorescent labeled markers distributed at 10 cM intervals throughout the genome (ABI PRISM Linkage Mapping Set MD10 version 2). Approximately 1.4 million genotypes were performed, which passed PCR quality control, but 2.21% of these were discarded for technical reasons (e.g. low intensity, contamination) or because they did not conform to Mendelian inheritance as determined by the PedCheck software package (34) or because they were reported to depend on a double recombination event with a probability of P , 0.005 using MERLIN (35) or SimWalk2 software (36) .
Comparison with results of other genome wide scans
We compared LOD scores found in the present study with the results of previous genome wide scans for hip or spine BMD (7,9,11 -14) . To provide an appropriate comparison between the studies, the LOD scores presented in this analysis were matched for skeletal site, sex and age group. For example, when comparing the results with those of previous studies in which pre-menopausal women had been analyzed, the LOD scores from this study presented are those in women ,50 years. When comparing the results with those of previous studies, which had analyzed men and women together over a range of ages, we also calculated LOD scores for men and women analyzed together in the whole study population. Where necessary, LOD scores for total hip BMD and Wards triangle and trochanter BMD were also calculated to provide site-specific comparisons.
Statistical analyses
At the outset of the study, our intention was to analyze the genome wide scan data from the whole study population for spine BMD and femoral neck BMD and to correct for the effects of age and sex, by entering these variables into the statistical model. By the time that the genome wide scan had been completed, however, it had become clear that there were sex-specific and age-specific determinants of BMD that could not be adequately captured by this approach (12,17 -19) . Because of this, we analyzed the genotype data conditioned by gender and age band (greater and less than 50), as well as in the study group as a whole. We made a Bonferroni adjustment on the basis of the assumption that we had conducted four independent genome wide searches for BMD at each skeletal site and under this scenario, the adjusted LOD scores increased from þ2.2 to þ2.8 for suggestive linkage and from þ3.6 to þ4.1 for significant linkage. Linkage analysis was carried out by the variance components methodology using SOLAR (37) and with a regression-based method of linkage analysis, implemented in the software MERLIN (35) . Multipoint LOD scores on the X-chromosome were calculated using the software minx (MERLIN for X) (35) . For these analyses, the LOD scores were adjusted for proband ascertainment, age, height, weight and height multiplied by weight. For the gender-specific and age-group specific analyses, all available genotyping data were used to assign identity-by-descent status. The gender-specific and age-specific linkage results were obtained by setting the BMD values for subjects who did not fall into the category of interest as missing values. Linkage analysis in the study group as a whole included the covariates mentioned previously, as well as gender. We excluded nine outlying, unusually high BMD values from the SOLAR analysis because they deviated by six or more standard deviations from the population mean. These outliers violate the assumption of normality that is made using variance components methodology and caused major discrepancies between the linkage peaks obtained using SOLAR and MERLIN. When the outliers were excluded, both methods gave almost identical results (data not shown). The data shown in the paper are from the SOLAR analysis with the exception of the X-chromosome data, which is from the MINX analysis. Simulation studies were conducted using a variance components model function of the QTDT software program to assess the statistical power of the study population to detect linkage. For these simulations, a model was constructed assuming an additive QTL with frequency 0.5, located 5 cM from the nearest microsatellite marker over a range of heritability estimates. For each scenario, we carried out 1000 simulations using the exact pattern of missing data that was observed in our data set and making the assumption of fully informative identity by descent. This analysis showed that the study had 98% power to detect a LOD score of þ3.3 for QTL of major effect, accounting for 30% of the heritability, and had 57% power to detect a LOD score of þ3.3 for a QTL accounting for 20% of the heritability.
